RSV Prevention in Newborns and Infants

Dear colleague and healthcare worker,

The protection of babies against the Respiratory Syncytial Virus (RSV) is a matter close to everyone's heart. This webpage, "RSV Prevention in Newborns and Infants," is an outline of the preventive campaign aimed at protecting newborns and young infants from severe RSV infections through immunization with Nirsevimab (Beyfortus™) for the 2026-2027 infection season.

The BAoP has committed to coordinate and monitor the implementation of the upcoming immunization through an RSV Task Force. This task force comprises various stakeholders.

Responsible and Coordination:

Dr. Marc Raes - Coordinator RSV prevention Force Force
Dr. Levi Hoste - Chair Scientific Task force BAoP

Secretariat:

Natacha Meignen

RSV information for healthcare workers

Prevention of RSV through Immunization with Monoclonal Antibodies in Young Children during Their First Year: Communication, Information, and Barriers

RSV information to give to parents

Customizable leaflets and posters for waiting rooms and / or consultation areas.